Atrial Fibrillation—New Antiarrhythmic Drugs

Gerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, Javier E Banchs, Erica Penny-Peterson, Robert Stevenson, Mario D Gonzalez
2007 US Cardiology Review  
Currently available antiarrhythmic drugs for the treatment of atrial fibrillation are limited in their efficacy and have potential for adverse effects, including torsade de pointes. With the aging of the population, the incidence of atrial fibrillation will double in frequency over the next 15 years.
doi:10.15420/usc.2007.4.2.71 fatcat:xaxmv4lucjaw7ohxjywy4vwldu